Glial cell line‐derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation
- 19 November 2002
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 454 (3) , 350-360
- https://doi.org/10.1002/cne.10480
Abstract
As with other cranial nerves and many CNS neurons, primary auditory neurons degenerate as a consequence of loss of input from their target cells, the inner hair cells (IHCs). Electrical stimulation (ES) of spiral ganglion cells (SGCs) has been shown to enhance their survival. Glial cell line‐derived neurotrophic factor (GDNF) has also been shown to increase survival of SGCs following IHC loss. In this study, the combined effects of the GDNF transgene delivered by adenoviral vectors (Ad‐GDNF) and ES were tested on SGCs after first eliminating the IHCs. Animal groups received Ad‐GDNF or ES or both. Ad‐GDNF was inoculated into the cochlea of guinea pigs after deafening, to overexpress human GDNF. ES‐treated animals were implanted with a cochlear implant electrode and chronically stimulated. A third group of animals received both Ad‐GDNF and ES (GDNF/ES). Electrically evoked auditory brainstem responses were recorded from ES‐treated animals at the start and end of the stimulation period. Animals were sacrificed 43 days after deafening and their ears prepared for evaluation of IHC survival and SGC counts. Treated ears exhibited significantly greater SGC survival than nontreated ears. The GDNF/ES combination provided significantly better preservation of SGC density than either treatment alone. Insofar as ES parameters were optimized for maximal protection (saturated effect), the further augmentation of the protection by GDNF suggests that the mechanisms of GDNF‐ and ES‐mediated SGC protection are, at least in part, independent. We suggest that GDNF/ES combined treatment in cochlear implant recipients will improve auditory perception. These findings may have implications for the prevention and treatment of other neurodegenerative processes. J. Comp. Neurol. 454:350–360, 2002.Keywords
Funding Information
- National Institute of Health-National Institute on Deafness and Other Communication Disorders (DC00078, DC03820, DC05188)
- Royal National Institute for the Deaf (RNID)
- Ruth and Lynn Townsend Professorship
This publication has 70 references indexed in Scilit:
- Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factorOncogene, 2000
- Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicityGene Therapy, 2000
- GDNF triggers a novel Ret‐independent Src kinase family‐coupled signaling via a GPI‐linked GDNF receptor α1FEBS Letters, 1999
- Hair Cell Protection from Aminoglycoside Ototoxicity by Adenovirus-Mediated Overexpression of Glial Cell Line-Derived Neurotrophic FactorHuman Gene Therapy, 1999
- Effects of Chronic Electrical Stimulation on Spiral Ganglion Neuron Survival and Size in Deafened KittensThe Laryngoscope, 1998
- Signal Transduction Pathways Activated by RET Oncoproteins in PC12 Pheochromocytoma CellsPublished by Elsevier ,1998
- Purification and Initial Characterization of Rat B49 Glial Cell Line‐Derived Neurotrophic FactorJournal of Neurochemistry, 1994
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- Chronic Electrical Stimulation of the Auditory Nerve in CatsActa Oto-Laryngologica, 1983
- Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation.The Laryngoscope, 1978